BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 1319331)

  • 1. Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons.
    Tatsuno I; Yada T; Vigh S; Hidaka H; Arimura A
    Endocrinology; 1992 Jul; 131(1):73-81. PubMed ID: 1319331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP and VIP stimulate Ca2+ oscillations in rat gonadotrophs through the PACAP/VIP type 1 receptor (PVR1) linked to a pertussis toxin-insensitive G-protein and the activation of phospholipase C-beta.
    Hezareh M; Schlegel W; Rawlings SR
    J Neuroendocrinol; 1996 May; 8(5):367-74. PubMed ID: 8736436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase-activating polypeptide (PACAP) mobilizes intracellular free calcium in cultured rat type-2, but not type-1, astrocytes.
    Tatsuno I; Arimura A
    Brain Res; 1994 Oct; 662(1-2):1-10. PubMed ID: 7859060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitatory effects of pituitary adenylate cyclase activating polypeptide (PACAP) on neurons in the magnocellular portion of the rat hypothalamic paraventricular nucleus (PVN) in vitro.
    Uchimura D; Katafuchi T; Hori T; Yanaihara N
    J Neuroendocrinol; 1996 Feb; 8(2):137-43. PubMed ID: 8868261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes.
    Grimaldi M; Cavallaro S
    Eur J Neurosci; 1999 Aug; 11(8):2767-72. PubMed ID: 10457173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE; Tatsuno I; Miyata A; Arimura A
    Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
    Margiotta JF; Pardi D
    Mol Pharmacol; 1995 Jul; 48(1):63-71. PubMed ID: 7623776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.
    Hernández M; Barahona MV; Recio P; Rivera L; Benedito S; Martínez AC; García-Sacristán A; Orensanz LM; Prieto D
    Br J Pharmacol; 2004 Jan; 141(1):123-31. PubMed ID: 14662737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived alpha T3-1 cell line.
    Schomerus E; Poch A; Bunting R; Mason WT; McArdle CA
    Endocrinology; 1994 Jan; 134(1):315-23. PubMed ID: 7903932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38)-, PACAP27-, and vasoactive intestinal peptide-stimulated responses in N1E-115 neuroblastoma cells.
    Chik CL; Inukai T; Ogiwara T; Boyd H; Li B; Karpinski E; Ho AK
    J Neurochem; 1996 Sep; 67(3):1005-13. PubMed ID: 8752106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
    Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
    Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced production of pituitary adenylate-cyclase-activating polypeptide by 1, N6-dibutyryladenosine 3',5'-monophosphate, phorbol 12-myristate 13-acetate and by the polypeptide itself in human neuroblastoma cells, IMR-32.
    Suzuki N; Harada M; Hosoya M; Fujino M
    Eur J Biochem; 1994 Jul; 223(1):147-53. PubMed ID: 7913440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effect of pituitary adenylate cyclase-activating polypeptide on aldosterone secretion in normal bovine and human tumorous adrenal cells.
    Bodart V; Babinski K; Ong H; De Léan A
    Endocrinology; 1997 Feb; 138(2):566-73. PubMed ID: 9002987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I; Gottschall PE; Arimura A
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.
    Suzuki A; Kotoyori J; Oiso Y; Kozawa O
    Cell Signal; 1994 Jan; 6(1):11-6. PubMed ID: 7912096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.